Varma Mutual Pension Insurance Co’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-49,147
Closed -$2.67M 337
2024
Q3
$2.67M Sell
49,147
-17,800
-27% -$1.63M 0.02% 306
2024
Q2
$7.95M Buy
+66,947
New +$8.47M 0.06% 284
2023
Q4
Sell
-25,000
Closed -$2.58M 332
2023
Q3
$2.58M Hold
25,000
0.03% 200
2023
Q2
$3.04M Hold
25,000
0.04% 203
2023
Q1
$3.84M Sell
25,000
-45,000
-64% -$7.42M 0.05% 185
2022
Q4
$12.6M Buy
70,000
+20,000
+40% +$3.27M 0.18% 117
2022
Q3
$5.91M Sell
50,000
-40,000
-44% -$6.07M 0.1% 156
2022
Q2
$12.9M Hold
90,000
0.21% 77
2022
Q1
$15.5M Buy
90,000
+50,000
+125% +$8.42M 0.18% 65
2021
Q4
$10.2M Hold
40,000
0.15% 86
2021
Q3
$15.4M Buy
40,000
+10,000
+33% +$3.69M 0.24% 63
2021
Q2
$7.05M Buy
30,000
+10,000
+50% +$1.79M 0.1% 113
2021
Q1
$2.62M Sell
20,000
-20,000
-50% -$2.9M 0.04% 169
2020
Q4
$4.18M Sell
40,000
-60,000
-60% -$6.07M 0.07% 107
2020
Q3
$7.08M Buy
+100,000
New +$6.97M 0.2% 90

Other funds holding MRNA

Varma Mutual Pension Insurance Co's MRNA Position: Q4 2024 in Review

Varma Mutual Pension Insurance Co sold out of Moderna (MRNA) in Q4 2024, closing a stake of 49,147 shares — an estimated $2.67M sold.

Varma Mutual Pension Insurance Co first reported a position in MRNA in Q3 2020 and held it in 15 quarters. The position peaked at $15.5M in Q1 2022. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Varma Mutual Pension Insurance Co reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Varma Mutual Pension Insurance Co sold 49,147 Moderna shares in Q4 2024, an estimated $2.67M.
  • Varma Mutual Pension Insurance Co first reported a position in Moderna in Q3 2020 and held it in 15 quarters.
  • Varma Mutual Pension Insurance Co's Moderna position peaked at $15.5M in Q1 2022.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Varma Mutual Pension Insurance Co's 13F filing for Q4 2024, filed 7 Feb 2025.